The Office of Prescription Drug Promotion (OPDP) of the U.S. Food and Drug Administration (FDA) conducted their latest Enforcement Webinar on November 19, 2012. During the webinar, OPDP gave stakeholders a chance to directly communicate with the Agency about clarifications or questions concerning recent Warning Letters and Untitled Letters issued by OPDP. This particular webinar covered Warning Letters and Untitled Letters issued from May 2012 through mid October 2012. You can download the slides that were discussed in this webinar by clicking the link below.
The content on this page is provided for reference purposes only. This content has not been altered or updated since it was archived.